The use of propranolol in the management of periocular capillary haemangioma - A systematic review

Eye

Volumn 25, Issue 10, 2011, Pages 1277-1283

  Spiteri Cornish, K ^a   Reddy, A R ^a  

^a ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

beta blocker; capillary haemangioma; haemangioma; orbital; periocular; propranolol

Indexed keywords

ACEBUTOLOL; PREDNISOLONE; PROPRANOLOL;

ASTHMA; ATOPIC DERMATITIS; BRONCHOSPASM; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CAPILLARY HEMANGIOMA; CARDIAC HYPERSENSITIVITY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; EYE CANCER; HEART DISEASE; HEMANGIOMA; HEMIFACIAL HEMANGIOMA; HUMAN; HYPOGLYCEMIA; HYPOTENSION; PATIENT COMPLIANCE; PERIOCULAR CAPILLARY HEMANGIOMA; PRACTICE GUIDELINE; RECURRENT CANCER; REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WHEEZING;

EID: 80054070968     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.164     Document Type: Review

References (41)

1. Gard R, Gupta N, Sharma A, Jain R, Beri S, D'Souza P. Acquired capillary haemangioma of the eyelid in a child. J Paediatr Ophthalmol Strabismus 2009; 46: 118-119.
2. Drolet BA, Esterly NB, Frieden IJ. Haemangiomas in children. N Engl J Med 1999; 341: 173-181.
3. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: Clinical application of a new classification. J Pediatr Surg 1983; 18: 894-899.
4. Cruz OA, Siegfried EC. Propranolol treatment for periocular capillary haemangiomas. J AAPOS 2010; 3: 251-256.
5. Fay A, Nguyen J, Jakobiec FA,Meyer-Junghaenel L,WanerM. Propranolol for isolated orbital infantile haemangioma. Arch Ophthalmol 2010; 128: 256-258.
6. Maguiness SM, Frieden IJ. Current management of infantile haemangiomas. Semin Cutan Med Surg 2010; 29: 106-114.
7. Tambe K,Munshi V, Dewsbery C, Ainsworth JR,Willshaw H, Parulekar MV. Relationship of infantile periocular haemangioma depth to growth and regression pattern. J AAPOS 2009; 13: 567-570.
8. Al Dhaybi R, Milet A, McCuaig C, Ospina L, Powell J. Treatment of periocular infantile haemangioma with propranolol: Review of 17 cases. Pediatr Dermatol 2009; 26: 665-666.
9. Ceisler E, Bleij F. Ophthalmic issues in haemangiomas of infancy. Lymphat Res Biol 2003; 4: 321-330.
10. Apfellberg DB, Maser MR, White DN, Lash H, Lane B, Marks MP. Benefits of contact and non-contact YAG laser for periorbital haemangiomas. Ann Plast Surg 1990; 24: 397-408.
11. Tronina SA, Bobrova NF, Khrinenko VP. Combined surgical method of orbital and periorbital haemangioma treatment in infants. Orbit 2008; 27: 249-257.
12. Léauté-Labréze C, Dumas de la Roque E, Hubiche T, Boralevi F. Propranolol for severe haemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
13. Haider KM, Plager DA, Neely DE, Eikenberry J, Haggstrom A. Outpatient treatment of periocular infantile haemangiomas with oral propranolol. J AAPOS 2010; 14: 251-256.
14. Sans V, Dumas de la Roque E, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J et al. Propranolol for severe infantile haemangiomas: Follow-up report. Pediatrics 2009; 124: 423-431.
15. Milet A, Al Dhaybi R, Superstein R, Powell J, Hamel P, Chevrette L et al. Propranolol for the treatment of periocular capillary haemangiomas. J AAPOS 2010; 14: E5.
16. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for haemangioma of infancy: Risks and recommendations. Pediatr Dermatol 2009; 26: 610-614.
17. Holmes WJM, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconst Aesth Surg 2010; 125: 420-427.
18. Bang G. Propranolol in treatment of capillary haemangiomas. Pediatric Ophthalmology Grand Rounds, University of Illinois Eye and Ear Infirmary, http:// www.uic.edu/com/eye (accessed on 31 October 2010).
19. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconst Aesth Surgery 2011; 64: 292-299.
20. Taban M, Goldberg RA. Propranolol for orbital haemangioma. Ophthalmology 2010; 117(1): 195-195.e4.
21. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile haemangioma. Arch Dermatol 2010; 146: 775-778.
22. Li YC, McCahon E, Rowe NA, Martin PA, Wilcsek GA, Martin FJ. Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol 2010; 38(6): 554-559.
23. Arneja JS, Pappas PN, Shwayder TA, Cullen ML, Becker CJ, Hamzavi FH et al. Management of complicated facial haemangiomas with beta-blocker (propranolol) therapy. Plast Reconstr Surg 2010; 126(3): 889-895.
24. Manunza F, Syed S, Laguda B, Linward J, Kennedy H, Gholam K et al. Propranolol for complicated infantile haemangiomas: A case series of 30 infants. Br J Dermat 2010; 162: 452-468.
25. Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma. Clin Exp Ophthalmol 2010; 38: 547-553.
26. Chik KK, Luk CK, Chan HB, Tan HY. Use of propranolol in infantile haemangioma among Chinese children. Hong Kong Med J 2010; 16: 341-346.
27. Fabian ID, Ben-Zion I, Samuel C, Spierer A. Reduction in astigmatism using propranolol as first-line therapy for periocular capillary haemangioma. Am J Ophthalmol 2011; 151: 53-58.
28. Mishra A, Holmes WJM, Gorst C, Liew SH. Role of propranolol in the management of periocular haemangiomas. Plast Refract Surg 2010; 2: 671.
29. Ernemann U, Kramer U, Miller S, Bisdas S, Rebmann H, Breuninger H et al. Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol 2010; 1: 2-11.
30. MicromedexR Healthcare Series. (Internet Database), Greewood Village, CO: ThomsonHealthcare. Updated periodically. Available at: Http://www.thomsonhc. com/hcs/librarian/ND-T/HCS/ ND-PR/Main/CS/FD86B3/DUPLICATIONSHIELDSYNC/ A57282/ND-PG/PRIH/ND-B/HCS/SBK/3/ND-P/Main/ PFPUI/6DTTNe2E3UQuC/PFActionId/hcs. common. RetrieveDocumentCommon/DocId/2119/ContentSetId/31/ sectionId/ adverseReactionsSection/SearchTerm/propranolol% 20/SearchOption/BeginWithip8 (accessed 31 October 2010).
31. Haik BG, Karcioglu ZA, Gordon RA, Pechous BP. Capillary haemangioma (infantile periocular haemangioma). Surv Ophthalmol 1994; 38: 399-426.
32. Bigorre M, Van Kien AK, Valette H. Beta-blocking agent for treatment of infantile haemangioma. Plast Reconstr Surg 2009; 6: 195e-196e.
33. Buckmiller LM. Propranolol treatment for infantile haemangiomas. Curr Opin Otolaryngol Head Neck Surg 2009; 6: 458-459.
34. Laquer V, Hoang V, Nguyen A, Kelly KM. Angiogenesis in cutaneous disease: Part II. J Am Acad Dermatol 2009; 61: 945-958.
35. Tucci FM, De Vincentiis GC, Sitzia E, Giusio L, Trozzi M, Bottero S. Head and neck vascular anomalies in children. Int J Paed Otorhinolaryngol 2009; 73S: S71-S76.
36. Boye E, Jinnin M, Olsen BR. Infantile haemangioma: Challenges, new insights, and therapeutic promise. J Craniofac Surg 2009; 20(Suppl 1): 678-684.
37. Love JN, Sikka N. Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med 2004; 26: 309e14.
38. Léauté-Labréze C, de la Roque ED, Taïeb A. More on propranolol for haemangiomas of infancy. N Engl J Med 2008; 26: 2846-2847.
39. Buckmiller LM, Richter GT, Suen JY. Diagnosis and management of haemangiomas and vascular malformations of the head and neck. Oral Dis 2010; 5: 405-418.
40. Halamek LP, Stevenson DK. Neonatal hypoglycaemia, part II: Pathophysiology and therapy. Clin Pediatr (Phila) 1998; 1: 11-16.
41. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile haemangiomas: A pilot study. Arch Dermatol. 2010; 5: 564-565.